Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.95% | 171.30 | 1.3% | $495.18m | |
| BIIB | Biogen Inc. | 0.91% | 235.04 | 1.3% | $480.36m | |
| CELG | Celgene Corporation | 0.11% | 96.36 | 1.3% | $457.23m | |
| GILD | Gilead Sciences, Inc. | -0.03% | 66.50 | 0.9% | $434.72m | |
| ILMN | Illumina, Inc. | 2.08% | 312.83 | 3.5% | $317.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.27% | 320.09 | 2.6% | $298.61m | |
| A | Agilent Technologies, Inc. | -0.50% | 67.98 | 1.6% | $207.68m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.92% | 172.37 | 1.9% | $181.17m | |
| EXAS | Exact Sciences Corporation | -2.10% | 94.91 | 25.3% | $163.66m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.97% | 127.55 | 2.0% | $149.64m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.25% | 87.69 | 4.3% | $118.55m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.36% | 121.62 | 14.7% | $112.14m | |
| INCY | Incyte Corporation | 0.43% | 79.02 | 2.5% | $105.72m | |
| IONS | Ionis Pharmaceuticals, Inc. | -0.98% | 68.56 | 8.2% | $98.74m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.09% | 67.81 | 9.2% | $94.94m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.